サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：人工子宮施設の世界市場2023-2030
市場調査レポート
商品コード
1296858

人工子宮施設の世界市場2023-2030

Global Artificial Womb Facility Market 2023-2030

出版日
ページ情報
英文 200 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
人工子宮施設の世界市場2023-2030
出版日: 2023年05月25日
発行: Orion Market Research
ページ情報: 英文 200 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

人工子宮施設の世界市場は、予測期間中にCAGR 8.9%の大幅な成長が見込まれています。市場成長を促進する主な要因には、早産の有病率の増加が含まれ、これは乳児に長期的な健康問題をもたらす可能性があります。人工子宮施設は、早産児の発育のためにより制御された支援的な環境を提供することで、早産児の転帰を改善する可能性があります。米国疾病予防管理センター（CDC）によると、米国における早産率は2020年の10.1％から2021年には10.5％と4％上昇しました。

市場の成長を後押ししているその他の要因としては、技術や医学研究の進歩があり、洗練された効果的な子宮外サポートシステムの開発が進んでいます。例えば、2022年1月、蘇州の研究開発は、人工子宮環境で胎児に成長する胚をモニターしケアする人工知能（AI）システムを開発しました。人工子宮、すなわち「長期胚培養装置」は、栄養価の高い液体で満たされた立方体の列の中でマウスの胚を成長させる容器です。さらに、AI技術により、機械が胚のわずかな変化の兆候を検出し、二酸化炭素、栄養、環境の投入を微調整するのに役立っており、システムは胚を健康と発育の可能性でランク付けすることさえできます。

セグメント別の展望

体外受精センター（IVF）サブセグメントは予測期間中CAGRで好成長

体外受精部門は良好な成長率で推移すると予測されます。結婚後の妊娠遅延と男性不妊症の増加が市場成長を促進する重要な要因です。妊娠の遅れは妊娠の合併症を引き起こし、不妊症の原因となるため、体外受精の成長を促進します。例えば、2022年3月の米国疾病予防管理センター（CDC）によると、女性の約5人に1人、つまり19％が1年間努力しても妊娠できない（不妊症）。体外受精技術の成功と体外受精の成功率の上昇が、世界的に体外受精技術の需要を刺激しています。さらに、国立周産期・統計ユニット（National Perinatal and Statistics Unit）の2021年9月の報告書によると、体外受精の成功率は過去10年間で大幅に改善し、卵子を使用する女性の体外受精開始周期あたりの生児出生率は全体で18％増加したことが実証されました。

地域別の見通し

欧州地域は人工子宮施設の世界市場において好成長が予測される

欧州地域は、世界の人工子宮施設市場において成熟した地域です。市場成長の主な要因は、特にEU地域における出生率の低下です。ポルトガルでは2010年以降人口が減少しており、国家統計局の予測によると、ポルトガルの人口は2060年までに1,050万人から630万人に減少する可能性があります。EUのユーロスタット機関は、2050年までにポルトガルは欧州で最も子どもの割合が少ない国になり、15歳未満の人口はわずか11.5％になると予測しています。おもちゃ屋や何百もの学校が閉鎖される一方で、ガソリンスタンドやモーテルが老人ホームに改築されつつあります。加えて、人工子宮施設の開発による規制機関の貢献が、市場成長をさらに後押しすると思われます。例えば、2022年2月、欧州の研究者は、子宮外で胎児が成長するのを助けることができる装置「人工子宮」を開発しました。この技術は、世界中で何百万人という未熟児で生まれる赤ちゃんを助け、その多くが病気や障害を抱えて成長します。

目次

第1章 レポート概要

  • 業界の現状分析と成長の可能性
  • 調査アプリケーションとツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • 人工子宮施設の世界市場：技術別
    • バイオリアクター
    • 子宮外サポートデバイス
    • その他の先端技術
  • 人工子宮施設の世界市場：用途別
    • 出生前ケア
    • 新生児ケア
  • 人工子宮施設の世界市場：エンドユーザー別
    • 超専門病院
    • 新生児ケアセンター
    • 研究センター
    • 体外受精センター（IVF）

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • American University of Beirut（AUB）
  • Biotex Inc.
  • California Preterm Birth Initiative
  • Emmaus Life Sciences, Inc.
  • Hebrew University
  • Institute of Life Sciences
  • Juno Perinatal Healthcare
  • Sera Prognostics, Inc.
  • Shanghai First Maternity and Infant Hospital
  • SomaGenics Inc.
  • Synthetix
  • The Children's Hospital of Philadelphia
  • TissUse GmbH
  • University Hospital Zurich
  • University of Pretoria
  • Virtus Health
  • Womn Institute
  • Zhejiang University
図表

LIST OF TABLES

  • 1. GLOBAL ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 2. GLOBAL BIOREACTORS FOR ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL EXTRAUTERIN SUPPORT DEVICES FOR ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL OTHER ADVANCED TECHNOLOGIES FOR ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 6. GLOBAL ARTIFICIAL WOMB FACILITY IN PRENATAL CARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL ARTIFICIAL WOMB FACILITY IN NEONATAL CARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 9. GLOBAL ARTIFICIAL WOMB FACILITY IN SUPER SPECIALITY HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL ARTIFICIAL WOMB FACILITY IN NEONATAL CARE CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL ARTIFICIAL WOMB FACILITY IN RESEARCH CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL ARTIFICIAL WOMB FACILITY IN IN-VITRO FERTILIZATION CENTERS (IVF) MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. EUROPEAN ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. EUROPEAN ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 17. EUROPEAN ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 19. EUROPEAN ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. EUROPEAN ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 21. EUROPEAN ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 22. EUROPEAN ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 25. ASIA-PACIFIC ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 26. ASIA-PACIFIC ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD ARTIFICIAL WOMB FACILITY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ARTIFICIAL WOMB FACILITY MARKET SHARE BY TECHNOLOGY, 2022 VS 2030 (%)
  • 2. GLOBAL BIOREACTORS FOR ARTIFICIAL WOMB FACILITY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL EXTRAUTERIN SUPPORT DEVICES FOR ARTIFICIAL WOMB FACILITY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL OTHER ADVANCED TECHNOLOGIES FOR ARTIFICIAL WOMB FACILITY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL ARTIFICIAL WOMB FACILITY MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 6. GLOBAL ARTIFICIAL WOMB FACILITY IN PRENATAL CARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL ARTIFICIAL WOMB FACILITY IN NEONATAL CARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL ARTIFICIAL WOMB FACILITY MARKET SHARE BY END-USER, 2022 VS 2030 (%)
  • 9. GLOBAL ARTIFICIAL WOMB FACILITY IN SUPER-SPECIALTY HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL ARTIFICIAL WOMB FACILITY IN NEONATAL CARE CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL ARTIFICIAL WOMB FACILITY IN RESEARCH CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL ARTIFICIAL WOMB FACILITY IN IN VITRO FERTILIZATION CENTERS (IVF) MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL ARTIFICIAL WOMB FACILITY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. US ARTIFICIAL WOMB FACILITY MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. CANADA ARTIFICIAL WOMB FACILITY MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. UK ARTIFICIAL WOMB FACILITY MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. FRANCE ARTIFICIAL WOMB FACILITY MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. GERMANY ARTIFICIAL WOMB FACILITY MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. ITALY ARTIFICIAL WOMB FACILITY MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. SPAIN ARTIFICIAL WOMB FACILITY MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. REST OF EUROPE ARTIFICIAL WOMB FACILITY MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. INDIA ARTIFICIAL WOMB FACILITY MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. CHINA ARTIFICIAL WOMB FACILITY MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. JAPAN ARTIFICIAL WOMB FACILITY MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. SOUTH KOREA ARTIFICIAL WOMB FACILITY MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. REST OF ASIA-PACIFIC ARTIFICIAL WOMB FACILITY MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD ARTIFICIAL WOMB FACILITY MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027344

Title:Global Artificial Womb Facility Market Size, Share & Trends Analysis Report by Technology (Bioreactors, Extrauterin Support Devices, and Other Advanced Technologies), By Application (Prenatal Care and Neonatal Care), and by End-User (Super-Specialty Hospitals, Neonatal Care Centers, Research Centers, and In-Vitro Fertilization Centers (IVF)), Forecast Period (2022-2030).

The global artificial womb facility market is anticipated to grow at a considerable CAGR of 8.9% during the forecast period. The key factor fueling the market growth include the increasing prevalence of preterm births, which can result in long-term health problems for the infant. Artificial womb facilities offer the potential to improve outcomes for premature infants by providing a more controlled and supportive environment for their development. According to the Centers for Disease Control and Prevention (CDC), the preterm birth rate rose 4% in 2021, from 10.1% in 2020 to 10.5% in 2021 in the US.

Other factors that are fueling the growth of the market include advances in technology and medical research, which are leading to the development of sophisticated and effective extra uterine support systems. For instance, in January 2022, Researchers in Suzhou developed an artificial intelligence (AI) system that monitors and take care of embryos as they grow into fetuses in an artificial womb environment. The artificial womb, or "long-term embryo culture device", is a container where they have mouse embryos grow in a line of cubes filled with nutritious fluids. Moreover, AI technology helps the machine detect the smallest signs of change in the embryos and fine-tune the carbon dioxide, nutrition and environmental inputs, and the system even ranks the embryos by health and development potential.

Segmental Outlook

The global artificial womb facility market is segmented based on the technology, application, and end-user. Based on the technology, the market is sub-segmented into bioreactors, extrauterine support devices, and other advanced technologies. Based on the application, the artificial womb facility market is bifurcated into prenatal care and neonatal care. Further, based on the end-user, the market is segmented into super specialty hospitals, neonatal care centers, research centers, and IVF centers.

In-Vitro Fertility Center (IVF) Sub-Segment to Grow at a Favorable CAGR During the Forecast Period

The in vitro fertility segment is projected to grow at a favorable rate. Delayed pregnancy after marriage coupled with a rise in male infertility are some crucial factors driving the market growth. Delayed pregnancies lead to complications in pregnancy, which gives rise to infertility and hence it drives the IVF growth. For instance, as per the Centers for Disease Control and Prevention (CDC) in March 2022, about 1 in 5 or 19% of women are unable to get pregnant after one year of trying (infertility). The rising success rate of IVF technology and rising success rates of IVF have stimulated the demand for in vitro fertilization techniques globally. Furthermore, the National Perinatal and Statistics Unit, September 2021 report, demonstrated that IVF success rates have improved significantly over the last 10 years, and the live birth rate per initiated IVF cycle in women using their eggs increased by 18% overall.

Regional Outlooks

The global artificial womb facility market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among these, North America holds a significant market share in the market, owing to the high prevalence of preterm births and rising focus on improving neonatal outcomes along with reducing infant mortality rates. According to the Marchofdimes Organization, in 2021, there were 383,979 preterm births in the US, representing 10.5% of live births. In 2021, 1 in 10 babies (10.5% of live births) was born preterm in the US.

Global Artificial Womb Facility Market Growth, by Region 2023-2030

Source: OMR Analysis

The European Region is Projected to Grow at a Favorable Rate in the Global Artificial Womb Facility Market

The European region is a mature region in the global artificial womb facility market. The major factor that drives the market growth is the lower fertility rate, especially in the EU region. In Portugal, the population has been shrinking since 2010, according to the projection of the National Statistics Institute Portugal's population could drop from 10.5 million to 6.3 million by 2060. The EU's Eurostat agency estimates that by 2050, Portugal will be the country in Europe that is home to the smallest proportion of children, with just 11.5% of the population expected to be under the age of 15. Toy shops and hundreds of schools are closing while petrol stations and motels are being converted into nursing homes. In addition, the contribution of regulatory bodies by developing artificial womb facilities will further drive market growth. For instance, in February 2022, European researchers developed an "artificial womb," a device which can help a fetus grow outside the uterus. Technology helps the millions of babies who are born premature around the world, as many grow to have illnesses or disability.

Market Players Outlook

The major companies serving the global artificial womb facility market include Juno Perinatal Healthcare, Sera Prognostics, Inc., TissUse GmbH, and others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2023, A group of German scientists created the world's first "artificial womb facility," where fertility specialists develop "designer babies," and parents-to-be can watch their fetus grow via smartphone app. The idea behind the artificial womb facility is that parents can watch their baby develop remotely while picking specific physical characteristics such as eye color, height, strength, and intelligence from a curated menu.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global artificial womb facility market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Application s and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight and Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 1.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Artificial Womb Facility Market by Technology
    • 4.1.1. Bioreactors
    • 4.1.2. Extrauterin Support Devices
    • 4.1.3. Other Advanced Technologies
  • 4.2. Global Artificial Womb Facility Market by Application
    • 4.2.1. Prenatal Care
    • 4.2.2. Neonatal Care
  • 4.3. Global Artificial Womb Facility Market by End-User
    • 4.3.1. Super Specialty Hospitals
    • 4.3.2. Neonatal Care Centers
    • 4.3.3. Research Centers
    • 4.3.4. In-Vitro Fertilization Centers (IVF)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. US
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. American University of Beirut (AUB)
  • 6.2. Biotex Inc.
  • 6.3. California Preterm Birth Initiative
  • 6.4. Emmaus Life Sciences, Inc.
  • 6.5. Hebrew University
  • 6.6. Institute of Life Sciences
  • 6.7. Juno Perinatal Healthcare
  • 6.8. Sera Prognostics, Inc.
  • 6.9. Shanghai First Maternity and Infant Hospital
  • 6.10. SomaGenics Inc.
  • 6.11. Synthetix
  • 6.12. The Children's Hospital of Philadelphia
  • 6.13. TissUse GmbH
  • 6.14. University Hospital Zurich
  • 6.15. University of Pretoria
  • 6.16. Virtus Health
  • 6.17. Womn Institute
  • 6.18. Zhejiang University